Friday, July 10, 2026

Drug profile · INN

differentiation

differentiation is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 3
News articles 0
Drug details — differentiation
Class
Route
Patents
20
Programs
3
Data quality
0.70

Quick answer

differentiation is an FDA-listed pharmaceutical active ingredient.

Key facts

INN differentiation

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. 20240178 Phase 3 · Amgen · Extensive stage small cell lung cancer (ES-SCLC).
  2. different degrees of adjustment of the injection interval Phase 3 · First People's Hospital · Exudative Age-Related Macular Degeneration
  3. IO-202 Phase 1 · BEONE MEDICINES AUS · AML With Monocytic Differentiation

Related patents

  1. US 12410403

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12389889

    Mouse having a humanized cluster of differentiation 47 gene

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12385013

    Differentiation of pancreatic endocrine cells

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 12385012

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 12371665

    Differentiation of pancreatic endocrine cells

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 12234460

    Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 12215355

    Stem cell derived islet differentiation

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 12173324

    Differentiation of pancreatic endocrine cells

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 12054517

    Myeloid differentiation factor 2 (MD2) signaling and modulation

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 12049645

    Differentiation of pancreatic endocrine cells

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 12006516

    Differentiation of pancreatic endocrine cells

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 11999971

    Stem cell derived islet differentiation

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 11992506

    Stem cell derived pancreatic islet differentiation

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 11910788

    Mouse having a humanized cluster of differentiation 47 gene

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 11891607

    Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 11891436

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 11760795

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 11634482

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 11634688

    Methods and compositions for inducing hematopoietic cell differentiation

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 11617769

    Methods of transdifferentiation and methods of use thereof

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is differentiation?

differentiation is an FDA-listed pharmaceutical active ingredient.